Federal judge denies Martin Shkreli all but one motion to dismiss monopoly claims in the FTC's Daraprim lawsuit

“Pharma Bro” Martin Shkreli filed motions in May to dismiss the FTC’s claims that his company Vyera Pharmaceuticals boxed out competition and created a monopoly for the toxoplasmosis drug Daraprim after raising prices by 4,000% overnight. But on Tuesday, a federal judge said not so fast.